| Literature DB >> 22110979 |
Giuseppe Caminiti1, Maurizio Volterrani, Giuseppe Marazzi, Anna Cerrito, Rosalba Massaro, Arianna Arisi, Alessio Franchini, Barbara Sposato, Giuseppe Rosano.
Abstract
Purpose. To assess if Tai Chi added to endurance training (ET) is more effective than ET alone in improving exercise tolerance and quality of life (QOL) of elderly patients with chronic heart failure (CHF). Design. Sixty CHF patients, age 73.8 ± 6 years, M/F 51/9, were enlisted. Thirty pts were randomized to combined training (CT) performing Tai Chi +ET and 30 patients to ET (ET only). Methods. At baseline and after 12 weeks all patients underwent 6-minute walking test (6MWT), assessment of amino terminal probrain natriuretic peptide (NT-pro BNP), quadriceps maximal voluntary contraction (MVC) and peak torque (PT), QOL questionnaire (MacNewQLMI), blood pressure (BP), and heart rate (HR). All patients performed 4 sessions of exercise/week. Results. Distance at 6mwt improved in both groups with significant between-groups differences (P = .031). Systolic BP and NT-proBNP decreased significant in the CT group compared to ET (P = .025) and P = .015), resp.). CT group had a greater significant improvement in physical perception (P = .026) and a significant increase of PT compared to ET group. Conclusions. The association of Tai Chi and ET improves exercise tolerance and QOL of patients with CHF more efficiently than ET.Entities:
Year: 2010 PMID: 22110979 PMCID: PMC3195859 DOI: 10.1155/2011/761958
Source DB: PubMed Journal: Rehabil Res Pract ISSN: 2090-2867
Baseline Features of the Overall Population and Patients of CT and ET groups.
| Overall population | CT ( | ET ( | |
|---|---|---|---|
| Age, years | 73.8 ± 6 | 74.1 ± 6 | 73.4 ± 2 |
| M/F | 51/9 | 25/5 | 26/4 |
| Cause of heart failure | |||
| Ischemic heart disease | 47 | 24 | 23 |
| Idiopathic dilated cardiomyopathy | 13 | 6 | 7 |
| BMI | 27.6 ± 3 | 27.8 ± 2 | 27.2 ± 3 |
| Hypertension | 42 | 19 | 23 |
| Atrial fibrillation | 12 | 7 | 5 |
| Diabetes | 28 | 15 | 13 |
| COPD | 23 | 11 | 12 |
| Echocardiography | |||
| LVDD, mm | 60.1 ± 5 | 59 ± 4 | 60 ± 6 |
| LVSD, mm | 45.9 ± 4 | 45 ± 5 | 46 ± 5 |
| Ejection fraction, % | 33.0 ± 9 | 33.6 ± 9 | 32.8 ± 12 |
| Treatment | |||
| Beta-blockers | 53 | 26 | 27 |
| ACE-i/ARBs | 58 | 28 | 30 |
| Diuretics | 35 | 18 | 17 |
| Aldosteron-antagonists | 38 | 18 | 20 |
| Statins | 42 | 23 | 19 |
| Digitalis | 22 | 13 | 9 |
BMI: body mass index
LVDD: left ventricular diastolic diameter
LVDD: left ventricular systolic diameter.
Comparison of Delta (Baseline versus 12 Weeks) of Hemodynamic, and Muscle Strength in the CT and ET Groups. Data Are Expressed as Mean ± Standard Deviation.
| CT group ( | ET group ( | Between-groups comparison | |||||
|---|---|---|---|---|---|---|---|
| Baseline | 12 weeks | Delta | Baseline | 12 weeks | Delta | ( | |
| Exercise tolerance | |||||||
| 6MWT, m | 214.9 ± 32 | 291.5 ± 46 | 77.4 ± 26 | 219.2 ± 23 | 272.0 ± 33 | 53.2 ± 16 | .031 |
| Hemodynamic | |||||||
| Heart rate, bpm | 72.3 ± 12 | 64.5 ± 11 | −8.2 ± 2.2 | 74.6 ± 11 | 69.5 ± 9 | −5.7 ± 1.6 | .074 |
| Systolic BP, mmHg | 131.3 ± 26 | 115.6 ± 23 | −13.4 ± 2.4 | 134.1 ± 29 | 127.7 ± 31 | −6.4 ± 1.3 | .025 |
| Diastolic BP, mmHg | 84.3 ± 14 | 79.6 ± 13 | −5.6 ± 1.4 | 83.9 ± 17 | 79.6 ± 14 | −4.3 ± 0.7 | .66 |
| NT pro-BNP, pg/mL | 136.4 ± 31 | 99.7 ± 22 | −36.7 ± 8 | 134.5 ± 28 | 111.7 ± 24 | −22.8 ± 7 | .015 |
| Muscle strength | |||||||
| MVC, N | 65.4 ± 15 | 83.6 ± 19 | 18.2 ± 4 | 66.0 ± 11 | 80.1 ± 20 | 14.1 ± 3 | .069 |
| PT, Nm | 41.3 ± 17.4 | 68.2 ± 9 | 26.9 ± 7 | 42.6 ± 17.4 | 56.7 ± 11 | 19 ± 1 | .037 |
6MWT: 6 minutes walking test
BP: blood pressure
NT pro-BNP: amino terminal probrain natriuretic peptide
MVC: maximal voluntary contraction
PT: peak torque.